Re: Zenith Updates

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Updates

in response to

Re: Zenith Updates

BearDownAZ

posted on Feb 02, 2016 07:02PM

Nice find, Bear.

I was trying to find the connection between Seton Hall and Zenith, but the only thing I know is that Ken Zuerblis, who is a director with both Resverlogix and Zenith, received his BSc from there. Maybe just coincidence.